Journals / MN Kardiyoloji / 2004 / Cilt: 11 - Sayı: 5

Relation of HOMA index and left ventricular function and structure with essential hypertension

Esansiyel hipertansiyonlu hastalarda HOMA indeksi ile sol ventrikül fonksiyonu ve yapısının ilişkisi

Pages
363–369
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: These results demonstrated that hypertensive patients had both abnormal cardiac structure and function and higher HOMA index.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The purpose of this study was to examine the relationship between left ventricular structure, function and HOMA index in patients with EH.
📊
Key Findings & Data:Material and Methods: We enrolled 73 patients (21 men, mean age 51.7±9.2 years) with untreated hypertension (BP>140 and/or 90 mmHg, fasting glycemia <110 mg/dl) and 64 healthy subjects without diabetes mellitus and hypertension (21 men, mean age 48.9±10.6 years) constituted the control group.
💡
Conclusion & Impact:Conclusions: These results demonstrated that hypertensive patients had both abnormal cardiac structure and function and higher HOMA index.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Hipertansiyon · Hipertrofi · sol ventrikül

Abstract

Aim: The purpose of this study was to examine the relationship between left ventricular structure, function and HOMA index in patients with EH. Material and Methods: We enrolled 73 patients (21 men, mean age 51.7±9.2 years) with untreated hypertension (BP>140 and/or 90 mmHg, fasting glycemia <110 mg/dl) and 64 healthy subjects without diabetes mellitus and hypertension (21 men, mean age 48.9±10.6 years) constituted the control group. In all subjects, transthoracic echocardiography was performed and blood samples were taken. Homeostasis model assessment (HOMA) was calculated by the formula: HOMA-index=Fasting blood glucose (mg/dl). *Immunoreactive insulin (µU/ml)/405 for the assessment of IR. Hypertensive patients were divided in two groups by mean HOMA index values. Each subject was examined for LV end-diastolic diameter, septal and posterior wall thickness, LV mass index (LVMI), fractional shortening (FS), mitral inflow velocity pattern, atrial filling fraction (AFF), left ventricular outflow velocity pattern and the total ejection isovolume index (TEI index). Results: The HOMA index (p<0.001), LVMI (p<0.001), AFF (p<0.0001), peak A velocity (p<0.028), septal (p<0.0001) and posterior (p<0.0001) wall thickness were significantly higher and FS (p<0.001), E/A ratio (p<0.0001) were significantly lower in hypertensive patients than healthy controls. LVMI (p<0.01) and septal wall thickness (p<0.001) were significantly higher in those hypertensive patients with higher HOMA index. HOMA-index was univariately related to TEI index (r=0.27, p=0.01) and septal wall thickness (IVS) (r=0.29, p=0.01) by Pearson correlation analysis in hypertensive patients. Conclusions: These results demonstrated that hypertensive patients had both abnormal cardiac structure and function and higher HOMA index. In our study group, the effect of hypertension on cardiac structure and function was correlated with HOMA index. Our results suggested that IR might be an important factor causing left ventricular dysfunction and wall increased thickness in non-diabetic patients with EH.

Özet

Amaç: Bu çalışmanın amacı, EH'li hastalarda sol ventrikül yapısı, fonksiyonu ve HOMA indeksi arasındaki ilişkiyi incelemektir. Gereç ve Yöntem: Tedavi edilmemiş hipertansiyonu bulunan 73 hasta (21 erkek, ortalama yaş 51.7±9.2) çalışmaya dahil edildi ve kontrol grubu olarak 64 sağlıklı olgu (21 erkek, ortalama yaş 48.9±10.6) seçildi. Tüm olgulara transtorasik ekokardiyografi yapıldı. İnsülin rezistans indeksi için HOMA-indeksi (Homeostasis model assessment) kullanıldı. HOMA-indeksi şu formülle hesaplandı: HOMA-indeksi=Açlık Kan Şekeri (mg/dl) *İmmünoreaktif insülin (µU/ml)/405. Hipertansif hastalar, ortalama HOMA indeksi değerlerine göre iki gruba ayrıldı. Her bir denek LV diyastol sonu çap, septal (İVS) ve posterior duvar kalınlığı, sol ventrikül kütle indeksi (SVKİ), fraksiyonel kısalma (FS), mitral inflow hız paterni, atriyal dolum fraksiyonu (AFF), sol ventrikül outflow hız paterni ve total ejeksiyon izovolüm indeksi (TEI indeksi) açısından incelendi. Bulgular: HOMA indeksi (p<0.001), SVKİ (p<0.001), AFF (p<0.0001), tepe A hızı (p<0.028), septal (p<0.0001) ve posterior (p<0.0001) duvar kalınlıkları hipertansif hastalarda kontrollere göre anlamlı şekilde daha yüksekti ve FS (p<0.001), E/A oranı (p<0.0001) anlamlı şekilde daha düşüktü. SVKİ (p<0.01) ve septal duvar kalınlığı (p<0.001), daha yüksek HOMA indeksi bulunan hipertansif hastalarda anlamlı şekilde daha büyüktü. Hipertansif hastalarda Pearson korelasyon analizi ile HOMA-indeksi, TEI indeksi (r=0.27, p=0.01) ve IVS (r=0.29, p=0.01) arasında anlamlı ilişki saptandı. SVKİ, FS ve mitral inflow hız paterni, HOMA indeksi ile ilişkili değildi. HOMA-indeksi stepwise regresyon analizinde bağımsız değişken olarak TEI indeksi (R2=0.20, p=0.0001) ve IVS (R2=0.12, p=0.002), ile anlamlı şekilde ilişkili bulundu. Sonuç: Hipertansif hastalarda hem anormal kalp yapısı ve fonksiyonu hem de daha yüksek HOMA indeksi bulunur. Kalp yapısı ve fonksiyonları üzerine hipertansiyonun etkisi HOMA indeksi ile koreledir. IR; EH'li non-diyabetik hastalarda sol ventrikül disfonksiyonuna ve duvar kalınlaşmasına sebep olan önemli bir faktör olabilir.

🔖

Cite This Article

EVRENGÜL, H., ZUNGUR, M., DURSUNOĞLU, D., KAFTAN, A., TANRIVERDİ, H., KILIÇ, M. (2004). Relation of HOMA index and left ventricular function and structure with essential hypertension. MN Kardiyoloji, Cilt: 11 - Sayı: 5, 363–369. https://ajindex.com/articles/297629

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implication of left ventricular mass in the Framingham Study. N Engl J Med 1990; 332:1541 -6. Casale PN, Devereux RD, Milner N, et al. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1992; 117:831 -6. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: the Framingham Study. N Engl J Med 1972; 287:781-7.
  2. Despre's JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart diseases. N Engl J Med 1996; 334:952-7.
  3. Duerr RL, McKiman MD, Gim RD, Clark RG, Chien KR, Ross J Jr. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 1996; 93:2188-96.
  4. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 1995; 13:1457-62.
  5. Paolisso G, Galzerano D, Gambardella A, et al. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 1995; 25:529-33.
  6. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow. Hypertension 1993; 21:129-35.
  7. Geffner ME, Golde DW. Selective insulin action on skin, ovary, and heart in insulin-resistant states. Diabetes Care 1988; 11:500-5.
  8. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance in metabolic syndrome. J Hypertens 1995; 13:433-8.
  9. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role on insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-81.
  10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insu¬ lin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia 1985; 28:412-9.
  11. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on Nomenclature and standards in two-dimensional imaging. Circulation 1980; 62:212-5.
  12. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-8.
  13. Tei C, Ling LH, Hodge DO, et al. New index of combined sy